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Balloon angioplasty as a treatment of failing
infrainguinal autologous vein bypass grafts
Gregory A. Carlson, MD, Jamal J. Hoballah, MD, William J. Sharp, MD, Mario Martinasevic, MD,
Kerri Maiers Yelden, MD, John D. Corson, MD, and Timothy F. Kresowik, MD, Iowa City, Iowa
Purpose: The purpose of this study was to evaluate the role of balloon angioplasty in the treatment of failing infrainguinal
vein bypass (IVB) grafts.
Methods: A retrospective chart review of patients undergoing revision of a failing IVB graft by vascular surgeons at a
tertiary care center from 1990 to 2001was performed. Failing bypass grafts were identified by routine duplex scan
surveillance and physical examination. The criteria for endovascular intervention varied on the basis of surgeon
preferences and time period; factors considered when choosing balloon angioplasty included significant comorbidities
that precluded operative intervention, the lack of adequate conduit for surgical revision, or poor accessibility of the
stenotic lesion. Data recorded included demographic patient data, type of IVB graft, patency status, further procedures
performed, and all complications and mortalities. Cumulative primary and assisted patency rates were calculated by using
Kaplan-Meier life-table analysis.
Results: A total of 45 balloon angioplasties were performed in 36 patients. There were 36 angioplasties of vein bypass
grafts, and additional balloon angioplasties were performed on nine of these patients. Locations of IVB grafts included
femoropopliteal (13 patients), femorodistal (13), and popliteal to distal (10). Initial success was achieved in 33 of 36 vein
bypass grafts (91.7%). In these bypass grafts, the stenotic lesions were identified and treated at the proximal anastomosis
(3 patients), mid-bypass graft (6 patients), and distal anastomosis (27 patients). Autogenous vein was used for all bypass
grafts. Cumulative vein bypass graft (life-table analysis) primary patency rates (those free of occlusion or bypass graft
threatening stenosis) were 74.2% at 6 months, 62.7% at 12 months, and 58.2% at 24 months. Repeat interventions
included surgical thrombectomy with vein patch angioplasty or bypass graft revision, as well as repeat balloon angioplasty
with or without thrombolysis. Cumulative assisted vein bypass graft patency rates (those free of occlusion or bypass graft
threatening stenosis) were 87.0%, 83.2%, and 78.9% at 6, 12, and 24 months, respectively. Two patients (4%) developed
thigh hematomas; no other procedure-related complications were noted, and there were no deaths in the perioperative
period.
Conclusion: Balloon angioplasty of failing infrainguinal vein bypass grafts can be successfully performed with a low rate
of complications. Acceptable short-term patency can be achieved. This procedure should be considered as an initial option
in failing IVB grafts. (J Vasc Surg 2004;39:421-6.)
Maintaining the patency of infrainguinal vein bypass
(IVB) grafts has long been a challenging task for vascular
surgeons. Although the etiology of bypass graft failure has
been well described, the mechanisms that result in bypass
graft failure remain poorly defined. Improvements in du-
plex ultrasound scanning technology and increased surveil-
lance of IVB grafts have allowed for the detection of a
subset of these bypass grafts that are at risk for thrombo-
sis.1-12 Considerable uncertainty still exists about the opti-
mal management of these threatened bypass grafts. In-
creased experience with endovascular therapies has lead to
the application of balloon angioplasty to the threatened
bypass graft,13-18 but the efficacy of this treatment modality
when compared with operative techniques, such as patch
angioplasty, interposition graft, or replacement graft, re-
mains unclear.
Three decades ago, Szilagyi et al19 first described the
potential lesions that can result when saphenous vein by-
pass grafts are used as arterial conduits. Their use of angiog-
raphy to evaluate vein bypass grafts revealed that a third
developed anatomical defects that might lead to thrombo-
sis. Attention has, therefore, turned to the identification of
those bypass grafts with defects before thrombosis has
occurred. Although intraoperative bypass graft angiogra-
phy, and more recently intraoperative duplex scan evalua-
tion,20 can be effective in identifying immediate technical
problems and vein bypass graft defects that can be imme-
diately corrected, most patients who develop bypass graft–
threatening defects do so in the first 6 to 12 months after
surgery.21 Routine surveillance angiography is impractical,
and ankle-brachial index (ABI) has been shown to be
somewhat unreliable in identifying all threatened bypass
grafts.11,22,23 The refinement of duplex ultrasound scan-
ning technology and surveillance techniques has enabled
vein bypass grafts with hemodynamic abnormalities to be
readily identified. Although the criteria used to define
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threatened vein bypass grafts vary slightly, the use of color
duplex scanning has been shown to accurately identify
those bypass grafts that are at risk of thrombosis. Further-
more, cost analysis suggests that patients who undergo
routine surveillance with duplex scans will incur less overall
cost because of decreased rates of amputation.22
Once a threatened vein bypass graft has been identified,
the surgeon must determine the best course of action to
maintain patency. Options for intervention include balloon
or patch angioplasty, interposition graft, or vein graft ex-
tension. This study evaluates the efficacy and safety of
balloon angioplasty of threatened IVB grafts in our recent
experience.
METHODS
A retrospective analysis of patients undergoing balloon
angioplasty by a vascular surgeon after IVB graft placement
was performed. The patients were identified by way of a
medical record search using ICD-9 (International Classifi-
cation of Diseases, 9th edition) codes. All charts were
reviewed, and the following data were recorded: age, gen-
der, weight, vascular risk factors (diabetes, hypertension,
hyperlipidemia, and smoking), surgical history (including
bypass graft types, dates, and locations), surveillance tech-
niques and findings, postoperative procedures, date and site
of balloon angioplasty, complications of balloon angio-
plasty, duration of follow-up, and bypass graft patency at
time of follow-up. In addition, the method and outcome of
any subsequent interventions were extracted from the med-
ical records. Outcomes of procedural success, morbidity
and mortality, and postprocedural patency were all evalu-
ated.
Infrainguinal vein bypass grafts were performed with a
variety of methods, including reversed, in situ, and free
nonreversed bypass grafts. Those bypass grafts that had
been performed at our institution were performed by one
of five board-certified vascular surgeons.
All IVB grafts were routinely followed with a color
duplex scan surveillance protocol after surgery; this proto-
col included evaluation immediately after bypass graft, then
at 3-month intervals for the first year, 6-month intervals for
the second year, and then annually. In addition, any vein
bypass grafts with abnormalities found on duplex scanning
were studied more frequently at 3-month intervals. Duplex
scanning was performed with the use of an Acuson 128 XP
color duplex scanner (Acuson Corp, Mountain View, Calif)
with either a 5- or 7.5-MHz linear array transducer. The
entire bypass graft was imaged with each study. Threatened
bypass grafts were defined as any bypass graft with an
increase in peak systolic velocity (PSV) to three times the
PSV in the rest of the bypass graft or an overall flow
decrease throughout the bypass graft with PSV  45 cm/
sec. The decision to perform balloon angioplasty versus
operative repair of these bypass grafts was made on an
individual basis. Long-segment stenoses (2 cm), bypass
grafts with multiple stenoses, and abnormalities detected
throughout the length of the bypass graft were considered
indications for surgical repair. Initially during the study
period, balloon angioplasty was reserved for patients with-
out adequate native vein for repair and for high-risk pa-
tients who were considered too great a surgical risk because
of severe medical conditions. Later in the series, some
surgeons preferred to use balloon angioplasty as an initial
method, whereas others continued to select certain patients
for endovascular intervention. Other than with those ste-
noses identified perioperatively, which were all treated sur-
gically, the timing of stenosis after bypass graft was not a
factor in determining the method of intervention. All bal-
loon angioplasties reported in this series were performed in
the operative suite by vascular surgeons trained in endovas-
cular techniques. Antegrade ipsilateral puncture was the
preferred technique, and balloon size was based on the
angiographic appearance of the bypass graft. Overinflation
and prolonged balloon inflation were not routinely used.
Balloon angioplasties performed by radiologists in the in-
terventional radiology suite were not included in this re-
view because different angioplasty indications, techniques,
and documentation were used by these clinicians. Angio-
grams were obtained either preoperatively or at the start of
the balloon angioplasty procedure. The size of the balloon
used for balloon angioplasty was based on the angiographic
appearance of the vein bypass graft and stenotic lesion. All
interventions were evaluated with completion angiograms.
Technical success was defined as a less than 30% stenosis
remaining on the completion angiogram. Vascular labora-
tory evaluation, including duplex scans, ankle-brachial in-
dices, and pulse-volume recordings, were obtained prior to
discharge. Restenoses were identified by using the same
duplex scan criteria listed earlier. Postangioplasty routines
varied on the basis of the patient’s overall medical status
and related vascular disease; all patients were on aspirin
daily.
Once all data had been collected, the primary and
assisted bypass graft patency rates of threatened IVB grafts
treated with balloon angioplasty were determined by using
Kaplan-Meier life-table analysis. Morbidity and mortality
rates were also calculated.
RESULTS
A total of 36 patients were identified who had under-
gone balloon angioplasty by a vascular surgeon for a threat-
ened IVB graft. The patient population included 23 men
and 13 women. The average age was 66.9 years (range,
38-87 years). Comorbidities included diabetes (66.7%),
hypertension (75.8%), hypercholesterolemia (42.4%), and
smoking (51.5%). The initial bypass graft operations on
these patients included femoropopliteal bypass graft (36%),
femorodistal bypass graft (36%), and popliteal to distal
bypass graft (28%). These bypass grafts included 13 re-
versed greater saphenous vein bypass grafts, 6 in situ bypass
grafts, 12 nonreversed greater saphenous vein bypass grafts,
3 composite bypass grafts, and 1 cryopreserved vein bypass
graft. The data about one bypass graft were not available, as
this bypass graft had been placed at an outside institution.
The exact lengths of stenoses were not uniformly recorded;
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however, we do not treat lesions 2 cm with balloon
angioplasty.
A total of 45 balloon angioplasties were attempted in
36 patients, with interventions evenly spaced over the study
period There were 36 balloon angioplasties of the vein
bypass grafts themselves, as well as 9 balloon angioplasties
of other lesions on the same patients. Balloon angioplasties
were performed on vein bypass grafts at the proximal
anastomosis in 3 vein bypass grafts (8%), mid-bypass graft
in 6 vein bypass grafts (17%), and the distal anastomosis in
27 vein bypass grafts (75%). Additionally, five patients
underwent balloon angioplasty of the external iliac artery,
and four patients underwent balloon angioplasty of distal
native arteries. Three of the patients who underwent bal-
loon angioplasty of the iliac lesions also had stent place-
ment. With regard to the balloon angioplasties performed
on the vein bypass grafts, initial technical success was
achieved in 33 of 36 bypass grafts (91.7%). Reasons for
failure at time of balloon angioplasty included persistent
stenosis in one patient and preprocedural thrombosis of the
threatened bypass graft in two patients. These patients
subsequently underwent surgical thrombectomy and revi-
sion with either interposition vein graft (one patient) or
extension vein graft (one patient). There were no major
complications and no deaths during the first 30 days after
balloon angioplasty. Minor complications consisted of two
patients (4%) with thigh hematomas, one of which required
surgical exploration and evacuation. These hematomas
were the result of puncture site bleeding and did not
represent vein bypass graft perforation or rupture.
A total of 33 vein bypass grafts were followed with
routine duplex scan surveillance, with an average follow-up
period of 26.8 months (longest, 138 months). One patient
was lost to follow-up. A total of 12 bypass grafts progressed
to occlusion, and 3 bypass grafts developed restenosis.
Cumulative primary stenosis-free patency (Kaplan-Meier
life-table analysis) rates were 74.2%, 62.7%, and 58.2% at 6,
12, and 24 months, respectively (Fig 1; Table I, online
only). Of the 15 bypass grafts that restenosed or occluded,
11events occurred within the first year after balloon angio-
plasty. The average time to restenosis or occlusion was 8.4
months after the initial procedure. A total of 7 patients
underwent secondary intervention, with interventions in-
cluding thrombectomy with vein patch angioplasty (1 pa-
tient), thrombectomy with vein graft extension (2 pa-
tients), and further balloon angioplasty (4 patients), with
thrombolysis in 2 of these patients. Six of these revisions
occurred within the first year. The resulting assisted steno-
sis-free patency rates (Kaplan-Meier life-table analysis) were
87.0%, 83.2%, and 78.9% at 6, 12, and 24 months, respec-
tively (Fig 2; Table II, online only).
One patient went on to require an above-knee ampu-
tation after occlusion of the femoropopliteal bypass graft 2
months after a balloon angioplasty. No other major ampu-
tations were performed, and there were no deaths attribut-
able to subsequent interventions for peripheral vascular
disease.
Of those bypass grafts that restenosed or thrombosed
after initially successful balloon angioplasty, 4 were femo-
ropopliteal bypass grafts, 5 were femorodistal bypass grafts,
and 6 were popliteal to distal bypass grafts. Of these pa-
tients, 2 had undergone balloon angioplasty of the proxi-
mal anastomosis, 3 had undergone balloon angioplasty of
the mid-bypass graft, and 10 had balloon angioplasty at the
distal anastomosis. Because of the small numbers involved
in each of these groups, no statistical analysis was per-
formed to evaluate the relative efficacy of balloon angio-
plasty in each individual type of bypass graft or location of
stenosis.
DISCUSSION
The optimal treatment of a threatened vein bypass graft
has sparked debate over the past several decades. Contro-
versy remains about the definition of a threatened vein
bypass graft and also the importance of the identified
stenotic lesion. The purpose of this study, however, was not
to answer the question of the efficacy of routine duplex scan
surveillance, as the authors use this method on all IVB
grafts. Our goal was to assess the outcome after balloon
angioplasty of a stenotic vein bypass graft lesion.
To determine the importance of our results, we must
first assess the historical success of the more traditional
Fig 1. Primary patency rate (no bypass graft threatening stenoses or occlusions).
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surgical intervention. Nehler et al24 published a large re-
view of patients who had undergone surgical revision of a
threatened IVB graft. Their revisions included inflow pro-
cedures (8%), patch angioplasties (7%), interposition vein
grafts (53%), and vein graft extensions (25%). They dem-
onstrated outstanding results, with cumulative patency
rates of 99% at 1 year and 96% at 3 years, as well as limb
salvage rates of 99% and 97% at one and three years,
respectively. They accomplished these results with a mor-
bidity rate of 13.6% and one mortality (1%). Individual
morbidities included myocardial infarction (3.4%), renal
insufficiency (1.7%), and congestive heart failure (1.7%).
Those investigators emphasized the importance of using
autogenous vein in the revision of these grafts. They used
autogenous vein in most of their cases. With excellent
results like those, it is unlikely that we can improve on
patency and limb salvage rates. However, given these mor-
bidity rates and the need for available vein, endovascular
revision could play a significant role in those patients who
are at higher anesthetic risk or who lack adequate vein for
surgical revision.
In addition to this assessment of surgical success rates,
several investigators have evaluated the efficacy of balloon
angioplasty in the treatment of vein bypass graft stenoses.
Tong et al13 reported 90 balloon angioplasties performed
on threatened IVB grafts with a cumulative stenosis-free
patency rate of 55.8% at 6 months, 54% at 1 year, and 45%
at 3 years. Those investigators noted a slightly improved
patency rate in those patients treated for a primary versus
recurrent stenosis. They reported no complications related
to their balloon angioplasties. Favre et al15 used balloon
angioplasty for select short stenoses of IVB grafts with
initial success rates similar to ours. They demonstrated a
91% initial success rate and cumulative patency rates at 1
and 2 years of 91% and 72%, respectively. Katz et al25
demonstrated slightly worse patency results, with an 8%
complication rate. They reported failure rates of 31% at 6
months, 55% at 1 year, and 63% at 2 years. These data
together demonstrate that there are some threatened IVB
grafts treated with balloon angioplasty that will go on to
occlude; however, acceptable patency rates can be achieved
with minimal morbidity. This is in concordance with our
findings. Although all of the above studies evaluated either
balloon angioplasty or surgical revision alone, there re-
mains the question of whether one method is superior
when compared directly.
Berkowitz et al26 reviewed a total of 78 threatened IVB
grafts treated over a 22-year period. They treated 81% with
a balloon angioplasty versus 19% with a surgical revision,
including patch angioplasty and short extension vein grafts.
They reported a 61% 5-year patency rate in those patients
treated with balloon angioplasty, compared with 29% of
surgically treated IVB grafts. It should be noted, however,
that some of their surgical group represented lesions previ-
ously treated with balloon angioplasty. In addition, their
subset analysis indicated that those bypass grafts with ste-
noses in mid-bypass graft and at the distal anastomosis that
were treated with balloon angioplasty, which represents
most of the patients from our study, had a higher restenosis
rate when compared with other lesions. Interestingly,
whereas our data were limited to those patients with short
stenotic lesions, those investigators were unable to demon-
strate a difference in patency between lesions longer and
shorter than 2 cm. More recently, Avino et al27 reviewed
various interventions on 144 vein graft stenoses. Their
patient population included a large array of sites of bypass
grafts, types of conduit, and types of intervention per-
formed. Overall they determined no difference in 2-year
patency rate between those bypass grafts treated surgically
(55%) and those treated with balloon angioplasty (63%).
The decision to perform one intervention versus the other
was based on clinical and duplex scan criteria. Bandyk et
al28 had previously reported a large series of patients with
threatened IVB grafts who had been treated by a variety of
methods, including patch angioplasty, bypass graft exten-
sion, and balloon angioplasty. They found that those le-
sions treated with a surgical revision had a lower incidence
of restenosis when compared with the patients treated with
balloon angioplasty (1 of 33 versus 9 of 18). Those inves-
tigators were also able to demonstrate excellent bypass graft
patency rates with secondary procedures for stenosis.
Fig 2. Secondary patency rate (no bypass graft threatening stenoses or occlusions).
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Unfortunately, those studies, along with our present
study, are difficult to compare. Multiple variations in the
treatment protocols exist, including different duplex scan
criteria to define a treatable stenosis, different inclusion
criteria for surgical versus endovascular repair, and different
surgical and endovascular techniques. In addition, the
treated lesions are difficult to compare directly, varying in
length, location, and severity. For instance, most lesions
treated in our patients were at the distal anastomosis site.
This fact might have lead to slightly decreased patency rates
when compared with other reports that included more
lesions from other parts of the bypass graft. These lesions
also represent a group that would likely require more
extensive surgical revision with an extension bypass graft.
In addition, in the presence of nonhealing ulcers or wounds
in the skin overlying the stenotic lesion, endovascular
methods offer an appealing alternative to surgery. Also, we
do not generally perform endovascular interventions on
vessels with diffuse disease or on long lesions (2 cm).
These variable factors likely contribute to the wide spec-
trum of patency rates reported in the studies above. The
variation in protocols makes comparing all of the available
data difficult at best. Other difficulties arise from the rela-
tively small number of patients studied in most series. Given
those numbers, conclusions are difficult to draw. Indeed,
none of our numbers were sufficient to warrant subgroup
analysis. From the standpoint of improved patency, how-
ever, no strong trends were noted that would indicate that
one lesion site would be better treated with balloon angio-
plasty.
A concerning finding in our data was a surprisingly
large number of vein bypass grafts that had occluded. Given
the frequent surveillance with duplex scans, we would have
expected to identify more restenoses than occlusions. On
further review, we found that several patients did not
present for follow-up duplex scanning examination as
scheduled. Specifically, one patient went for 1 year without
evaluation after initially undergoing duplex scan studies at
3 and 6 months. In another patient, the 3-month evalua-
tion was missed, and the patient subsequently presented
with a thrombosed graft. Finally, one patient stopped pre-
senting for studies after 6 months of postoperative evalua-
tion and then presented with a thrombosed graft in just less
than 1 year after the bypass graft. The specific reasons for
missed follow-up appointments could not be readily ob-
tained. Furthermore, some patients who were high risk for
surgery or poor candidates for further intervention were no
longer followed with an eye toward further intervention.
Also, some patients occluded early after balloon angio-
plasty. Finally, some patients who had healed their foot
wounds no longer required further revascularization. De-
spite the number of thrombosed bypass grafts, we were able
to demonstrate good assisted patency rates by using a
combination of endovascular and surgical secondary inter-
ventions.
The three patients who could not undergo balloon
angioplasty at the time of planned intervention should also
be noted. In one case, the balloon angioplasty was inade-
quate to achieve angiographic resolution of the stenosis. In
the other two cases in whom balloon angioplasty could not
be performed, thrombosis occurred in the interim between
diagnosis of the stenotic lesion and treatment. This result
underlines the importance of responding to threatened
bypass grafts quickly and decisively. Both of these patients
underwent successful surgical revision of their bypass grafts.
In summary, our data suggest several conclusions and
add to the growing understanding of the role of endovas-
cular interventions for threatened IVB grafts. Specifically,
balloon angioplasty can be performed on threatened IVB
grafts with a low rate of morbidity and mortality. Initial
success and short-term patency of threatened vein bypass
grafts is acceptable. Given these findings, balloon angio-
plasty represents an option for the initial correction of
well-selected lesions in threatened IVB grafts, such as le-
sions that could require extensive dissection and those
arising in high-risk patients. Further evaluation with well-
controlled, prospective studies should project more light
on this difficult clinical problem. Continued surveillance is
imperative to define patients with recurrent stenoses after
balloon angioplasty procedures; in addition, more intensive
surveillance, initially at 1-month intervals, might be war-
ranted after these interventions.
REFERENCES
1. Ihlberg L, Luther M, Tierala E, Lepantalo M. The utility of Duplex
scanning in infrainguinal vein graft surveillance: Results from a random-
ized controlled study. Eur J Vasc Endovasc Surg 1998;16:19-27.
2. Wilson YG, Davies AH, Currie IC, Morgan M, McGrath C, Baird RN,
et al. The value of pre-discharge Duplex scanning in infrainguinal graft
surveillance. Eur J Vasc Endovasc Surg 1996;10:237-42.
3. Dougherty MJ, Calligaro KD, DeLaurentis DA. The natural history of
“failing” arterial bypass grafts in a duplex surveillance protocol. Ann
Vasc Surg 1998;12:255-9.
4. Mills JL, Harris EJ, Taylor LM Jr, Beckett WC, Porter JM. The
importance of routine surveillance of distal bypass grafts with duplex
scanning: A study of 379 reversed vein grafts. J Vasc Surg 1990;12:379-
89.
5. Calligaro KD, Syrek JR, Dougherty MJ, Rua I, McAffee-Bennett S,
Doerr KJ, et al. Selective use of duplex ultrasound to replace preopera-
tive arteriography for failing arterial vein grafts. J Vasc Surg 1998;27:
89-95.
6. Mills JL, Bandyk DF, Gahtan V, Esses GE. The origin of infrainguinal
vein graft stenosis: A prospective study based on duplex surveillance. J
Vasc Surg 1995;21:16-25.
7. Papanicolaou G, Zierler RE, Beach KW, Isaacson JA, Strandness DE Jr.
Hemodynamic parameters of failing infrainguinal bypass grafts. Am J
Surg 1995;169:238-44.
8. Robison JG, Elliott BM. Does postoperative surveillance with duplex
scanning identify the failing distal bypass? Ann Vasc Surg 1991;5:182-5.
9. Buth J, Disselhoff B, Sommeling C, Stam L. Color-flow duplex criteria
for grading stenosis in infrainguinal vein grafts. J Vasc Surg 1991;14:
716-28.
10. McShane MD, Gazzard VM, Clifford PC, Humphries KN, Webster JH,
Chant AD. Duplex ultrasound monitoring of arterial grafts: Prospective
evaluation in conjunction with ankle pressure indices after femorodistal
bypass. Eur J Vasc Surg 1987;1:385-90.
11. Bergamini TM, George SM Jr, Massey HT, Henke PK, Klamer TW,
Lambert GE, et al. Intensive surveillance of femoropopliteal-tibial
autogenous vein bypasses improves long-term graft patency and limb
salvage. Ann Surg 1995;221:507-15.
12. Mattos MA, van Bemmelen PS, Hodgson KJ, Ramsey DE, Barkmeier
LD, Sumner DS. Does correction of stenoses identified with color
JOURNAL OF VASCULAR SURGERY
Volume 39, Number 2 Carlson et al 425
duplex scanning improve infrainguinal graft patency? J Vasc Surg 1993;
17:54-66.
13. Tong Y, Matthews PG, Royle JP. Outcome of endovascular interven-
tion for infrainguinal vein graft stenosis. Cardiovasc Surg 2002;10:545-
50.
14. Martin DR, Katz SG, Kohl RD, Qian D. Percutaneous transluminal
angioplasty of infrainguinal vessels. Ann Vasc Surg 1999;13:184-7.
15. Favre JP, Malouki I, Sobhy M, Gay JL, Gournier JP, Barral X. Angio-
plasty of distal venous bypasses: is it worth the cost? J Cardiovasc Surg
1996;37(3 suppl 1):59-65.
16. Gonsalves C, Bandyk DF, Avino AJ, Johnson BL. Duplex features of
vein graft stenosis and the success of percutaneous transluminal angio-
plasty. J Endovasc Surg 1999;6:66-72.
17. Wilson YG, Davies AH, Curie IC, McGrath C, Morgan M, Baird RN, et
al. Vein graft stenosis: Incidence and intervention. Eur J Vasc Endovasc
Surg 1996;11:164-9.
18. Sullivan TR Jr, Welch HJ, Iafrati MD, Mackey WC, O’Donnell TF Jr.
Clinical results of common strategies used to revise infrainguinal vein
grafts. J Vasc Surg 1996;24:909-19.
19. Szilagyi DE, Elliott JP, Hageman JH, Smith RF, Dall’olmo CA. Bio-
logic fate of autogenous vein implants as arterial substitutes: Clinical,
angiographic and histopathologic observations in femoro-popliteal op-
erations for atherosclerosis. Ann Surg 1973;178:232-46.
20. Bandyk DF, Mills JL, Gahtan V, Esses GE. Intraoperative duplex
scanning of arterial reconstructions: Fate of repaired and unrepaired
defects. J Vasc Surg 1994;20:426-33.
21. Mills JL, Fujitani RM, Taylor SM. The characteristics and anatomic
distribution of lesions that cause reversed vein graft failure: A five-year
prospective study. J Vasc Surg 1993;17:195-206.
22. Visser K, Idu MM, Buth J, Engel GL, Hunink MGM. Duplex scan
surveillance during the first year after infrainguinal autologous vein
bypass grafting surgery: Costs and clinical outcomes compared with
other surveillance programs. J Vasc Surg 2001;33:123-30.
23. Laborde AL, Synn AY, Worsey MJ. A prospective comparison of
ankle/brachial indices and color duplex imaging in surveillance of the in
situ saphenous vein bypass. J Cardiovasc Surg 1992;33:420-5.
24. Nehler MR, Moneta GL, Yeager RA, Edwards JM, Taylor LM Jr, Porter
JM. Surgical treatment of threatened reversed infrainguinal vein grafts.
J Vasc Surg 1994;20:558-65.
25. Katz SG, Alexander JQ. The efficacy of percutaneous angioplasty in
infrainguinal vein bypass graft stenosis [abstract]. Proceedings of the
Western Vascular Society, November 20, 2002. Newport Beach (Calif):
The Society; 2002.
26. Berkowitz HD, Fox AD, Deaton DH. Reversed vein graft stenosis:
Early diagnosis and management. J Vasc Surg 1992;15:130-42.
27. Avino AJ, Bandyk DF, Gonsalves AJ, Johnson BL, Black TJ, Zwiebel
BR, et al. Surgical and endovascular intervention for infrainguinal vein
graft stenosis. J Vasc Surg 1999;29:60-71.
28. Bandyk DF, Bergamini TM, Towne JB, Schmitt DD, Seabrook GR.
Durability of vein graft revision: the outcome of secondary procedures.
J Vasc Surg 1991;13:200-10.
Submitted Mar 26, 2003; accepted Jul 31, 2003.
Additional material for this article may be found online
at www.mosby.com/jvs.
JOURNAL OF VASCULAR SURGERY
February 2004426 Carlson et al
